Acción 301033 MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Medprin Regenerative Medical Technologies Co., Ltd.

Acciones

301033

CNE100004NB8

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 07/05/2024 		Varia. Cinco días. Varia. 1 de enero.
37,8 CNY +4,02 % Gráfico intradía de Medprin Regenerative Medical Technologies Co., Ltd. +9,57 % -13,18 %
24/04 Medprin Regenerative Medical Technologies Co. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
18/04 Medprin Regenerative Medical Technologies Co. Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.
Medprin Regenerative Medical Technologies Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.
Medprin Regenerative Medical Technologies Co., Ltd. authorizes a Buyback Plan.
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023.
Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023
Medprin Regenerative Medical Technologies Co., Ltd. Proposes Profit Distribution of Cash Dividend for the Year 2022
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Medprin Regenerative Medical Gets Marketing Nod in China for Craniofacial Fixation Plate
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2022.
Medprin Regenerative Medical Technologies to Free Up 2.5% Stake For Trading
Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021
Medprin Regenerative Medical Technologies Co., Ltd. Announces Profit Distribution for 2021
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 301033
  4. Noticias Medprin Regenerative Medical Technologies Co., Ltd.
  5. Otros idiomas